GSK R&D vet Russo jumps to Genenta, takes a lead role in developing a new gene therapy
GSK vet Carlo Russo is joining up with some of his former gene therapy colleagues, taking the chief medical officer’s role at Milan-based Genenta …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
